SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001683168-20-000556
Filing Date
2020-02-21
Accepted
2020-02-21 09:39:16
Documents
12

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 5899
2 PART II AND III cbd_1aa7.htm PART II AND III 1813747
3 CERTIFICATE OF AMENDMENT TO RESTATED ARTICLES OR AMENDED AND RESTATED ARTICLES cbd_ex0204.htm EX1A-2A CHARTER 6924
4 GRAPHIC logo.jpg GRAPHIC 34896
5 GRAPHIC image_001.jpg GRAPHIC 9809
6 GRAPHIC image_002.jpg GRAPHIC 2543
7 GRAPHIC image_005.jpg GRAPHIC 3173
8 GRAPHIC image_003.jpg GRAPHIC 4722
9 GRAPHIC image_006.jpg GRAPHIC 371364
10 GRAPHIC image_010.jpg GRAPHIC 319902
11 GRAPHIC image_008.jpg GRAPHIC 33391
12 GRAPHIC image_009.jpg GRAPHIC 235340
  Complete submission text file 0001683168-20-000556.txt   3226931
Mailing Address 10855 N. 116TH STREET, SUITE 115 SCOTTSDALE AZ 85259
Business Address 10855 N. 116TH STREET, SUITE 115 SCOTTSDALE AZ 85259 480-410-6780
CBD Life Sciences Inc. (Filer) CIK: 0001776073 (see all company filings)

IRS No.: 205118532 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 1-A/A | Act: 33 | File No.: 024-11005 | Film No.: 20637596
SIC: 2833 Medicinal Chemicals & Botanical Products